Clinical Trials Browser

Phase 1 × Interventional × Quillaja Saponins × Clear all

NCT06741072 2026-01-08

BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

Phase 1 Suspended

Renal Insufficiency, Chronic